U.S. Sepsis Diagnostics Market Size & Outlook, 2022-2030
U.S. sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
U.S. sepsis diagnostics market highlights
- The U.S. sepsis diagnostics market generated a revenue of USD 384.2 million in 2022 and is expected to reach USD 655.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.9% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2022 | USD 384.2 million |
| Market revenue in 2030 | USD 655.5 million |
| Growth rate | 6.9% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, U.S. accounted for 38.4% of the global sepsis diagnostics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 114.6 million by 2030.
Blood culture media was the largest segment with a revenue share of 38.99% in 2022. Horizon Databook has segmented the U.S. sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
Sepsis is a severe and potentially life-threatening condition caused by organ dysfunction resulting from infection. The prevalence of sepsis is highest among older adults and individuals with underlying health conditions; however, it can be detected in anyone with an infection.
The U.S. accounted for the leading share of North America's sepsis diagnostics market. The National Healthcare Safety Network (NHSN) annual survey in 2022 investigated the characteristics and prevalence of sepsis programs in acute care hospitals.
The presence of these committees significantly varied with hospital size, ranging from 53% in hospitals with 0–25 beds to 95% in those with over 500 beds. In addition, 55% of hospitals provided dedicated time either protected time or specific job descriptions for leaders of these committees to manage sepsis programs and perform daily tasks.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. sepsis diagnostics market size, by product, 2018-2030 (US$M)
U.S. Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
